Guidelines for community-acquired pneumonia (CAP) treatment have been published since 1993. Currently, the guidelines developed under the auspices of the Infectious Diseases Society of America and the American Thoracic Society are used. Empirical antibiotic recommendations reported in the current guidelines have not changed significantly from those reported previously concerning the choice of antibiotics, whereas the treatment duration is generic. Actually, in clinical practice, it seems that patients with mild-to-moderate CAP are overtreated for 7-10 days. The concern regarding adverse drug interactions, drug costs and, especially, increasing antimicrobial resistance have led to attempts to shorten the duration of therapy for CAP. © 2007 Future Drugs Ltd.
Community-acquired pneumonia: Is it time to shorten the antibiotic treatment?
Fiore M.
2007
Abstract
Guidelines for community-acquired pneumonia (CAP) treatment have been published since 1993. Currently, the guidelines developed under the auspices of the Infectious Diseases Society of America and the American Thoracic Society are used. Empirical antibiotic recommendations reported in the current guidelines have not changed significantly from those reported previously concerning the choice of antibiotics, whereas the treatment duration is generic. Actually, in clinical practice, it seems that patients with mild-to-moderate CAP are overtreated for 7-10 days. The concern regarding adverse drug interactions, drug costs and, especially, increasing antimicrobial resistance have led to attempts to shorten the duration of therapy for CAP. © 2007 Future Drugs Ltd.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
